RNA5SP194: A Potential Drug Target and Biomarker (G100873456)

Target Name: RNA5SP194

NCBI ID: G100873456

RNA5SP194

Other Name(s): RNA, 5S ribosomal pseudogene 194 | RN5S194

RNA5SP194: A Potential Drug Target and Biomarker

RNA5SP194 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the and cell cycle, and its levels have been found to be altered in various diseases, including cancer. RNA5SP194 has also been shown to have diagnostic potential, with levels of RNA5SP194 being significantly increased in the blood of patients with cancer.

The drug targeting aspect of RNA5SP194 is its ability to interact with and drugs, leading to the potential for use as a drug target. RNA5SP194 has been shown to interact with various drugs, including inhibitors of the PI3K/Akt signaling pathway, which is known to be involved in various cellular processes, including cell proliferation and survival.

RNA5SP194 has also been shown to play a role in the regulation of the cell cycle. It has been shown to be involved in the G1 phase of the cell cycle, which is when the cell prepares for cell division. Additionally, RNA5SP194 has been shown to be involved in the regulation of the G2 phase of the cell cycle, which is when the cell prepares for cell division.

RNA5SP194 has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die naturally. It has been shown to be involved in the regulation of apoptosis, which is the process by which cells die naturally.

The biomarker aspect of RNA5SP194 is its ability to serve as a marker for the presence of cancer. It has been shown to be significantly increased in the blood of patients with cancer, making it a potential biomarker for cancer diagnosis.

Conclusion

In conclusion, RNA5SP194 is a non-coding RNA molecule that has the potential to be a drug target and biomarker. Its ability to interact with drugs and its involvement in the regulation of the cell cycle and apoptosis make it a promising candidate for drug targeting. Further research is needed to determine its potential as a drug target and biomarker.

Protein Name: RNA, 5S Ribosomal Pseudogene 194

The "RNA5SP194 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP194 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets